Mangoceuticals (MGRX) Gross Profit (2023 - 2026)
Mangoceuticals' (MGRX) quarterly Gross Profit came in at $44215.0 in Q2 2026, down 50.84% year-over-year from $89948.0 in Q2 2025, and up 52.46% quarter-over-quarter from $29001.0 in Q1 2026.
Analysis
Mangoceuticals (MGRX) Gross Profit (2023 - 2026) Analysis & Trends
Mangoceuticals has disclosed Gross Profit across 4 years of filings, most recently posting $44215.0 for Q2 2026.
- In Q2 2026, Gross Profit fell 50.84% year-over-year to $44215.0; the TTM figure through Jun 2026 stood at $171590.0 (down 45.49% YoY), while the FY2025 annual figure was $250386.0, down 34.1% from the prior year.
- Gross Profit came in at $44215.0 for Q2 2026 at Mangoceuticals, up from $29001.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $147398.0 in Q1 2024 to a low of $29001.0 in Q1 2026.
- Average Gross Profit over 4 years is $81076.2, with a median of $74947.5 recorded in 2024.
- Year-over-year, Gross Profit surged 157.69% in 2024 and slumped 57.89% in 2025.
- Over 4 years, Gross Profit stood at $142583.0 in 2023, then sank by 43.82% to $80103.0 in 2024, then plunged by 40.73% to $47475.0 in 2025, then declined by 6.87% to $44215.0 in 2026.
- Per Business Quant data, the three most recent Gross Profit figures were $44215.0 in Q2 2026, $29001.0 in Q1 2026, and $47475.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Hinge Health | 7.41 Bn | 7.03 Bn | 183.95 Mn |
| 2 | Hims & Hers Health | 6.47 Bn | 5.63 Bn | 480.80 Mn |
| 3 | Ethos Technologies | 2.54 Bn | 2.37 Bn | 185.54 Mn |
| 4 | Omada Health | 1.38 Bn | 1.16 Bn | 63.79 Mn |
| 5 | Teladoc Health | 1.14 Bn | 366.41 Mn | 416.09 Mn |
| 6 | Talkspace | 870.58 Mn | 779.48 Mn | 24.80 Mn |
| 7 | Akso Health | 259.44 Mn | 259.25 Mn | - |
| 8 | LifeMD | 147.29 Mn | 147.29 Mn | - |
| 9 | eHealth | 31.71 Mn | -69.34 Mn | - |
| 10 | Mangoceuticals | 7.39 Mn | 7.14 Mn | 44,215.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44,215.00 |
| Mar 31, 2026 | 29,001.00 |
| Dec 31, 2025 | 47,475.00 |
| Sep 30, 2025 | 50,899.00 |
| Jun 30, 2025 | 89,948.00 |
| Mar 31, 2025 | 62,064.00 |
| Dec 31, 2024 | 80,103.00 |
| Sep 30, 2024 | 82,671.00 |
| Jun 30, 2024 | 69,792.00 |
| Mar 31, 2024 | 147,398.00 |
| Dec 31, 2023 | 142,583.00 |
| Sep 30, 2023 | 144,589.00 |
| Jun 30, 2023 | 87,130.00 |
| Mar 31, 2023 | 57,199.00 |